Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
Κύριοι συγγραφείς: | S. Hatakeyama, T. Yoneyama, Y. Tobisawa, H. Yamamoto, A. Imai, Y. Hashimoto, C. Ohyama |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
Elsevier
2020-07-01
|
Σειρά: | European Urology Open Science |
Διαθέσιμο Online: | http://www.sciencedirect.com/science/article/pii/S2666168320336442 |
Παρόμοια τεκμήρια
-
N‐glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas
ανά: Hirotake Kodama, κ.ά.
Έκδοση: (2021-02-01) -
Serum N-Glycan Profiling Predicts Prognosis in Patients Undergoing Hemodialysis
ανά: Shingo Hatakeyama, κ.ά.
Έκδοση: (2013-01-01) -
Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
ανά: Itsuto Hamano, κ.ά.
Έκδοση: (2020-07-01) -
Clinical implications of serum N‐glycan profiling as a diagnostic and prognostic biomarker in germ‐cell tumors
ανά: Takuma Narita, κ.ά.
Έκδοση: (2017-04-01) -
Hyaluronic acid degrading enzyme: TMEM2 increase in patients with interstitial cystitis and bladder pain syndrome
ανά: H. Yamamoto, κ.ά.
Έκδοση: (2020-07-01)